Background: In recent years, great research interest has been directed to the diagnostic, therapeutic and marker role of Preferentially expressed Antigen in Melanoma (PRAME) in the setting of various human neoplasms. Although it has been extensively studied mainly in the differential diagnosis setting of melanocytic pigmented lesions, still very few papers have analyzed the usefulness or otherwise of PRAME in the context of other non-melanoma skin cancers (NMSC). (2) Methods: In this paper, we report the data of our experience of 21 cases of sebaceous carcinoma (SC) classified in the three WHO grade and collected in the period between January 2005 and 31 October 2022, on which immunostaining for PRAME was performed; Non-parametric Mann–Whit...
Preferentially expressed antigen in melanoma (PRAME) is a tumor-associated repressor of retinoic aci...
PRAME (PReferentially expressed Antigen in MElanoma), a cancer-testis antigen expressed in normal an...
Cutaneous T-cell lymphomas (CTCLs) are rare tumors with no established markers that can reliably dis...
Background: Preferentially expressed antigen in melanoma (PRAME) is a cancer testis antigen (CTA) id...
(1) Background: Fine-needle aspiration cytology is often used for the pre-operative diagnosis of mel...
(1) Background: Fine-needle aspiration cytology is often used for the pre-operative diagnosis of mel...
Background: PReferentially expressed Antigen in MElanoma (PRAME) immunohistochemistry is increasingl...
: PRAME (PReferentially expressed Antigen in MElanoma), a cancer testis antigen expressed in low lev...
: PRAME (PReferentially expressed Antigen in MElanoma), a cancer testis antigen expressed in low lev...
Background: Preferentially expressed antigen in melanoma (PRAME) has been widely investigated in the...
Background: Preferentially expressed antigen in melanoma (PRAME) has been widely investigated in the...
Background: Rhabdoid melanoma is a rare variant of malignant melanoma with characteristic cytomorpho...
: PRAME (PReferentially expressed Antigen in MElanoma) is a tumor-associated antigen that was recent...
: PRAME (PReferentially expressed Antigen in MElanoma) is a tumor-associated antigen that was recent...
PubMedID: 26044287Objectives: Although Hodgkin's lymphoma (HL) is one of the most curable cancers in...
Preferentially expressed antigen in melanoma (PRAME) is a tumor-associated repressor of retinoic aci...
PRAME (PReferentially expressed Antigen in MElanoma), a cancer-testis antigen expressed in normal an...
Cutaneous T-cell lymphomas (CTCLs) are rare tumors with no established markers that can reliably dis...
Background: Preferentially expressed antigen in melanoma (PRAME) is a cancer testis antigen (CTA) id...
(1) Background: Fine-needle aspiration cytology is often used for the pre-operative diagnosis of mel...
(1) Background: Fine-needle aspiration cytology is often used for the pre-operative diagnosis of mel...
Background: PReferentially expressed Antigen in MElanoma (PRAME) immunohistochemistry is increasingl...
: PRAME (PReferentially expressed Antigen in MElanoma), a cancer testis antigen expressed in low lev...
: PRAME (PReferentially expressed Antigen in MElanoma), a cancer testis antigen expressed in low lev...
Background: Preferentially expressed antigen in melanoma (PRAME) has been widely investigated in the...
Background: Preferentially expressed antigen in melanoma (PRAME) has been widely investigated in the...
Background: Rhabdoid melanoma is a rare variant of malignant melanoma with characteristic cytomorpho...
: PRAME (PReferentially expressed Antigen in MElanoma) is a tumor-associated antigen that was recent...
: PRAME (PReferentially expressed Antigen in MElanoma) is a tumor-associated antigen that was recent...
PubMedID: 26044287Objectives: Although Hodgkin's lymphoma (HL) is one of the most curable cancers in...
Preferentially expressed antigen in melanoma (PRAME) is a tumor-associated repressor of retinoic aci...
PRAME (PReferentially expressed Antigen in MElanoma), a cancer-testis antigen expressed in normal an...
Cutaneous T-cell lymphomas (CTCLs) are rare tumors with no established markers that can reliably dis...